RE:RE:Biogen's Aduhelm ...no - I'm pretty sure you're wrong Chi-Chi.
Biogen is having problems.
Let me share some headlines to help you out - to jog your memory !
That's OK though - like I said, bar is set low - it will make it easier to bring something better to market.
Go back to all those Incyte shares you purchased - they're calling you! hahaha!
-----
Biogen’s $20 Billion Slide Wipes Out Boost From Alzheimer’s Drug
-----
Rocky start for Biogen’s Alzheimer’s drug Aduhelm
Controversial Alzheimer’s treatment Aduhelm is struggling to realise its potential, with only 100 patients receiving the therapy so far in the US
-----
FDA head calls for investigation into approval of Biogen Alzheimer’s drug
The acting head of the Food and Drug Administration on Friday called for a government investigation into highly unusual contacts between some of her agency’s drug reviewers and the maker of a controversial new Alzheimer’s drug.
-----
The road to Aduhelm: What one ex-FDA adviser called 'probably the worst drug approval decision in recent US history' for an Alzheimer's treatment
-----
With Medicare Undecided On Whether To Pay, Alzheimer’s Drug Maker Biogen Offers Free Doses